| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.831 | 0.002 | 0.831 | 5 Hydroxytryptamine 1F antagonist | 0.665 0.003 DBMET00245 | ||
| 0.709 | 0.013 | 0.779 | Analgesic | 0.779 0.007 DBMET00245 | DBMET00245 | |
| 0.693 | 0.006 | 0.693 | Spasmolytic | 0.683 0.007 DBMET02774 0.625 0.011 DBMET00245 | ||
| 0.685 | 0.004 | 0.685 | 5 Hydroxytryptamine 7 antagonist | 0.557 0.004 DBMET00245 | ||
| 0.652 | 0.005 | 0.679 | Psychostimulant | 0.377 0.026 DBMET02774 0.679 0.005 DBMET00245 | DBMET00245 | |
| 0.582 | 0.005 | 0.582 | P-glycoprotein inhibitor | 0.261 0.038 DBMET02774 0.512 0.008 DBMET00245 | ||
| 0.593 | 0.02 | 0.593 | Aldehyde oxidase inhibitor | 0.204 0.103 DBMET00245 | ||
| 0.575 | 0.013 | 0.575 | Histamine release inhibitor | 0.513 0.024 DBMET02774 0.508 0.026 DBMET00245 | ||
| 0.587 | 0.057 | 0.608 | Antiinflammatory | 0.608 0.051 DBMET02774 0.567 0.063 DBMET00245 | DBMET02774 | |
| 0.538 | 0.01 | 0.538 | Anticonvulsant | 0.464 0.015 DBMET00245 | ||
| 0.521 | 0.005 | 0.521 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.442 0.014 DBMET00245 | ||
| 0.491 | 0.008 | 0.491 | Anesthetic general | 0.212 0.068 DBMET02774 0.391 0.018 DBMET00245 | ||
| 0.462 | 0.005 | 0.462 | Nav1.2 sodium channel blocker | 0.439 0.005 DBMET00245 | ||
| 0.46 | 0.004 | 0.46 | Nav1.3 sodium channel blocker | 0.454 0.004 DBMET00245 | ||
| 0.447 | 0.003 | 0.447 | 5 Hydroxytryptamine 5A antagonist | 0.293 0.004 DBMET00245 | ||
| 0.476 | 0.033 | 0.476 | Vasodilator, peripheral | 0.249 0.128 DBMET02774 0.38 0.062 DBMET00245 | ||
| 0.46 | 0.019 | 0.46 | HERG channel blocker | 0.241 0.07 DBMET00245 | ||
| 0.42 | 0.002 | 0.42 | Sphingomyelinase inhibitor | 0.147 0.026 DBMET02774 0.378 0.003 DBMET00245 | ||
| 0.481 | 0.068 | 0.481 | Caspase 9 stimulant | 0.301 0.193 DBMET02774 0.412 0.104 DBMET00245 | ||
| 0.418 | 0.006 | 0.418 | Anesthetic local | 0.331 0.01 DBMET00245 | ||
| 0.412 | 0.003 | 0.412 | 5 Hydroxytryptamine 5 antagonist | 0.291 0.004 DBMET00245 | ||
| 0.406 | 0.005 | 0.408 | Alpha 2b adrenoreceptor antagonist | 0.408 0.005 DBMET00245 | DBMET00245 | |
| 0.441 | 0.045 | 0.458 | GABA C receptor rho-3 antagonist | 0.458 0.039 DBMET00245 | DBMET00245 | |
| 0.419 | 0.024 | 0.419 | Potassium channel (Voltage-sensitive) blocker | 0.238 0.073 DBMET00245 | ||
| 0.399 | 0.005 | 0.516 | 5 Hydroxytryptamine uptake inhibitor | 0.516 0.004 DBMET00245 | DBMET00245 | |
| 0.387 | 0.006 | 0.387 | Acetylcholine M1 receptor antagonist | 0.144 0.081 DBMET02774 0.321 0.011 DBMET00245 | ||
| 0.391 | 0.038 | 0.391 | Vasodilator, coronary | 0.33 0.066 DBMET02774 0.354 0.053 DBMET00245 | ||
| 0.428 | 0.077 | 0.508 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.508 0.03 DBMET00245 | DBMET00245 | |
| 0.376 | 0.027 | 0.376 | Potassium channel blocker | 0.19 0.1 DBMET00245 | ||
| 0.37 | 0.027 | 0.37 | Sigma receptor agonist | 0.216 0.057 DBMET00245 | ||
| 0.346 | 0.011 | 0.346 | Cholinergic antagonist | 0.196 0.033 DBMET02774 0.283 0.016 DBMET00245 | ||
| 0.346 | 0.011 | 0.346 | 5 Hydroxytryptamine 2B antagonist | 0.244 0.02 DBMET00245 | ||
| 0.339 | 0.004 | 0.526 | Adrenaline uptake inhibitor | 0.526 0.003 DBMET00245 | DBMET00245 | |
| 0.379 | 0.05 | 0.603 | 5 Hydroxytryptamine release stimulant | 0.603 0.014 DBMET00245 | DBMET00245 | |
| 0.329 | 0.005 | 0.329 | Alpha 2c adrenoreceptor antagonist | 0.323 0.005 DBMET00245 | ||
| 0.334 | 0.011 | 0.334 | Cytokine production inhibitor | 0.217 0.031 DBMET00245 | ||
| 0.322 | 0.004 | 0.324 | 5 Hydroxytryptamine 3E antagonist | 0.324 0.004 DBMET00245 | DBMET00245 | |
| 0.383 | 0.067 | 0.432 | Transcription factor NF kappa B inhibitor | 0.413 0.061 DBMET02774 0.432 0.057 DBMET00245 | DBMET00245 | |
| 0.322 | 0.008 | 0.322 | Acetylcholine muscarinic antagonist | 0.226 0.019 DBMET02774 0.247 0.015 DBMET00245 | ||
| 0.324 | 0.012 | 0.324 | Acetylcholine antagonist | 0.17 0.04 DBMET02774 0.263 0.018 DBMET00245 | ||
| 0.315 | 0.006 | 0.315 | Histamine H1 receptor antagonist | 0.214 0.013 DBMET00245 | ||
| 0.324 | 0.018 | 0.324 | RET inhibitor | 0.314 0.02 DBMET00245 | ||
| 0.312 | 0.009 | 0.312 | Antihistaminic | 0.244 0.015 DBMET00245 | ||
| 0.314 | 0.012 | 0.314 | Adenylate cyclase inhibitor | 0.216 0.023 DBMET02774 0.285 0.015 DBMET00245 | ||
| 0.306 | 0.004 | 0.306 | 5 Hydroxytryptamine 1D antagonist | 0.22 0.005 DBMET00245 | ||
| 0.305 | 0.009 | 0.305 | Histamine antagonist | 0.237 0.015 DBMET00245 | ||
| 0.296 | 0.004 | 0.296 | Acetylcholine M4 receptor antagonist | 0.162 0.009 DBMET00245 | ||
| 0.295 | 0.007 | 0.295 | Alpha 2a adrenoreceptor antagonist | 0.285 0.007 DBMET00245 | ||
| 0.289 | 0.007 | 0.289 | ATPase inhibitor | 0.18 0.057 DBMET02774 0.28 0.008 DBMET00245 | ||
| 0.282 | 0.009 | 0.282 | Alpha 2 adrenoreceptor antagonist | 0.272 0.01 DBMET00245 | ||
| 0.289 | 0.017 | 0.289 | 5 Hydroxytryptamine 2 antagonist | 0.258 0.02 DBMET00245 | ||
| 0.308 | 0.054 | 0.308 | DNA damaging | 0.229 0.093 DBMET02774 0.279 0.066 DBMET00245 | ||
| 0.26 | 0.011 | 0.26 | 5 Hydroxytryptamine 2C antagonist | 0.229 0.014 DBMET00245 | ||
| 0.253 | 0.006 | 0.253 | 5 Hydroxytryptamine 1B antagonist | 0.192 0.009 DBMET00245 | ||
| 0.284 | 0.041 | 0.296 | 5 Hydroxytryptamine 1E antagonist | 0.296 0.032 DBMET00245 | DBMET00245 | |
| 0.263 | 0.021 | 0.263 | Antipruritic | 0.263 0.021 DBMET00245 | ||
| 0.243 | 0.01 | 0.243 | Nav1.4 sodium channel blocker | 0.126 0.047 DBMET02774 0.238 0.011 DBMET00245 | ||
| 0.287 | 0.054 | 0.287 | Ca(v)3.3 blocker | 0.22 0.152 DBMET00245 | ||
| 0.245 | 0.015 | 0.245 | 5 Hydroxytryptamine 2A antagonist | 0.198 0.02 DBMET00245 | ||
| 0.269 | 0.044 | 0.269 | Platelet aggregation inhibitor | 0.209 0.075 DBMET00245 | ||
| 0.306 | 0.084 | 0.44 | Antithrombotic | 0.44 0.04 DBMET02774 0.326 0.074 DBMET00245 | DBMET02774 | |
| 0.225 | 0.004 | 0.225 | Acetylcholine M5 receptor antagonist | 0.17 0.006 DBMET00245 | ||
| 0.229 | 0.009 | 0.229 | Alcohol dehydrogenase inhibitor | 0.094 0.059 DBMET02774 0.174 0.015 DBMET00245 | ||
| 0.258 | 0.039 | 0.258 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.172 0.105 DBMET02774 0.164 0.118 DBMET00245 | ||
| 0.277 | 0.061 | 0.277 | Platelet antagonist | 0.269 0.064 DBMET02774 0.274 0.062 DBMET00245 | ||
| 0.267 | 0.053 | 0.275 | Tyrosine 3 hydroxylase inhibitor | 0.275 0.047 DBMET00245 | DBMET00245 | |
| 0.281 | 0.071 | 0.3 | Insulysin inhibitor | 0.3 0.058 DBMET00245 | DBMET00245 | |
| 0.237 | 0.027 | 0.237 | 5 Hydroxytryptamine antagonist | 0.192 0.036 DBMET00245 | ||
| 0.271 | 0.063 | 0.275 | 5 Hydroxytryptamine uptake stimulant | 0.275 0.06 DBMET00245 | DBMET00245 | |
| 0.347 | 0.141 | 0.365 | Apoptosis agonist | 0.365 0.131 DBMET02774 0.327 0.154 DBMET00245 | DBMET02774 | |
| 0.225 | 0.02 | 0.225 | DNA intercalator | |||
| 0.21 | 0.006 | 0.21 | Acetylcholine M2 receptor antagonist | 0.142 0.012 DBMET00245 | ||
| 0.215 | 0.013 | 0.215 | Mediator release inhibitor | 0.182 0.018 DBMET00245 | ||
| 0.208 | 0.006 | 0.208 | Acetylcholine M3 receptor antagonist | 0.167 0.009 DBMET00245 | ||
| 0.211 | 0.01 | 0.211 | Dopamine D1 antagonist | 0.144 0.016 DBMET00245 | ||
| 0.221 | 0.021 | 0.224 | Antiadrenergic | 0.224 0.02 DBMET00245 | DBMET00245 | |
| 0.257 | 0.057 | 0.257 | Antimitotic | 0.159 0.113 DBMET00245 | ||
| 0.205 | 0.005 | 0.256 | Histamine H2 receptor antagonist | 0.256 0.004 DBMET00245 | DBMET00245 | |
| 0.22 | 0.023 | 0.22 | Calcium channel blocker | 0.162 0.05 DBMET00245 | ||
| 0.199 | 0.006 | 0.199 | Dopamine uptake inhibitor | 0.184 0.007 DBMET00245 | ||
| 0.22 | 0.028 | 0.22 | Acetylcholinesterase inhibitor | 0.132 0.068 DBMET02774 0.133 0.067 DBMET00245 | ||
| 0.198 | 0.009 | 0.198 | Prolactin inhibitor | 0.115 0.042 DBMET00245 | ||
| 0.201 | 0.013 | 0.201 | Calcium antagonist | 0.097 0.05 DBMET00245 | ||
| 0.284 | 0.102 | 0.343 | Cholesterol antagonist | 0.343 0.067 DBMET02774 0.231 0.139 DBMET00245 | DBMET02774 | |
| 0.197 | 0.015 | 0.214 | Adenylate cyclase stimulant | 0.137 0.087 DBMET02774 0.214 0.009 DBMET00245 | DBMET00245 | |
| 0.187 | 0.006 | 0.187 | Histamine N-methyltransferase inhibitor | 0.132 0.022 DBMET00245 | ||
| 0.194 | 0.014 | 0.194 | Photosensitizer | 0.121 0.056 DBMET00245 | ||
| 0.218 | 0.039 | 0.218 | Cholinergic | 0.116 0.113 DBMET02774 0.135 0.09 DBMET00245 | ||
| 0.201 | 0.023 | 0.204 | Adrenaline antagonist | 0.204 0.023 DBMET00245 | DBMET00245 | |
| 0.19 | 0.015 | 0.19 | GABA C receptor antagonist | 0.176 0.019 DBMET00245 | ||
| 0.202 | 0.027 | 0.202 | Alpha adrenoreceptor antagonist | 0.192 0.029 DBMET00245 | ||
| 0.19 | 0.018 | 0.19 | 5 Hydroxytryptamine 1 antagonist | 0.14 0.025 DBMET00245 | ||
| 0.198 | 0.027 | 0.221 | Topoisomerase I inhibitor | 0.221 0.022 DBMET02774 | DBMET02774 | |
| 0.199 | 0.028 | 0.199 | Neurotrophic factor | 0.137 0.072 DBMET00245 | ||
| 0.239 | 0.069 | 0.262 | Cyclic AMP phosphodiesterase inhibitor | 0.262 0.058 DBMET02774 | DBMET02774 | |
| 0.192 | 0.022 | 0.192 | Nav1.6 sodium channel blocker | 0.163 0.041 DBMET00245 | ||
| 0.229 | 0.063 | 0.272 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.272 0.051 DBMET00245 | DBMET00245 | |
| 0.18 | 0.017 | 0.198 | Alpha 1b adrenoreceptor antagonist | 0.198 0.015 DBMET00245 | DBMET00245 | |
| 0.169 | 0.008 | 0.169 | Protein kinase C alpha inhibitor | 0.068 0.047 DBMET02774 0.134 0.013 DBMET00245 | ||
| 0.169 | 0.01 | 0.171 | Beta tubulin antagonist | 0.171 0.01 DBMET00245 | DBMET00245 | |
| 0.176 | 0.018 | 0.204 | Nav1.5 sodium channel blocker | 0.204 0.012 DBMET00245 | DBMET00245 | |
| 0.165 | 0.008 | 0.165 | Calcium channel L-type blocker | 0.121 0.016 DBMET00245 | ||
| 0.23 | 0.077 | 0.23 | Neuropeptide Y2 antagonist | 0.196 0.126 DBMET00245 | ||
| 0.168 | 0.019 | 0.168 | Heat shock protein 70 antagonist | 0.142 0.067 DBMET02774 0.152 0.042 DBMET00245 | ||
| 0.156 | 0.014 | 0.165 | Alpha 1d adrenoreceptor antagonist | 0.165 0.013 DBMET00245 | DBMET00245 | |
| 0.146 | 0.005 | 0.146 | Kinesin-like protein 1 inhibitor | 0.07 0.012 DBMET00245 | ||
| 0.146 | 0.005 | 0.146 | Kinesin antagonist | 0.07 0.012 DBMET00245 | ||
| 0.231 | 0.095 | 0.231 | Cardiotonic | |||
| 0.141 | 0.007 | 0.141 | 5 Hydroxytryptamine 6 antagonist | 0.11 0.012 DBMET00245 | ||
| 0.139 | 0.007 | 0.149 | Beta 3 adrenoreceptor antagonist | 0.149 0.006 DBMET00245 | DBMET00245 | |
| 0.16 | 0.029 | 0.16 | Calcium channel (voltage-sensitive) blocker | 0.125 0.051 DBMET00245 | ||
| 0.149 | 0.02 | 0.149 | Telomerase inhibitor | 0.067 0.055 DBMET00245 | ||
| 0.158 | 0.031 | 0.17 | GABA C receptor agonist | 0.17 0.027 DBMET00245 | DBMET00245 | |
| 0.22 | 0.094 | 0.375 | DNA synthesis inhibitor | 0.375 0.025 DBMET02774 0.185 0.147 DBMET00245 | DBMET02774 | |
| 0.173 | 0.048 | 0.224 | GABA C receptor rho-2 antagonist | 0.224 0.019 DBMET00245 | DBMET00245 | |
| 0.142 | 0.019 | 0.154 | CYP2A6 inhibitor | 0.154 0.015 DBMET00245 | DBMET00245 | |
| 0.148 | 0.028 | 0.148 | Gastric antisecretory | 0.146 0.029 DBMET00245 | ||
| 0.122 | 0.004 | 0.122 | 5 Hydroxytryptamine 3B antagonist | 0.089 0.005 DBMET00245 | ||
| 0.212 | 0.095 | 0.212 | Vasodilator | 0.155 0.149 DBMET02774 0.155 0.15 DBMET00245 | ||
| 0.153 | 0.036 | 0.153 | Ferrochelatase inhibitor | 0.134 0.045 DBMET00245 | ||
| 0.128 | 0.011 | 0.128 | Acyl-CoA dehydrogenase inhibitor | 0.057 0.036 DBMET02774 0.075 0.024 DBMET00245 | ||
| 0.148 | 0.033 | 0.148 | Protein kinase C gamma inhibitor | 0.116 0.055 DBMET00245 | ||
| 0.178 | 0.063 | 0.178 | Phospholipase C inhibitor | 0.161 0.086 DBMET02774 0.146 0.114 DBMET00245 | ||
| 0.149 | 0.035 | 0.182 | Papain-like protease (SARS coronavirus) inhibitor | 0.182 0.015 DBMET00245 | DBMET00245 | |
| 0.15 | 0.037 | 0.15 | Falcipain 3 inhibitor | 0.107 0.064 DBMET00245 | ||
| 0.135 | 0.022 | 0.135 | 5 Hydroxytryptamine 1A antagonist | 0.099 0.033 DBMET00245 | ||
| 0.158 | 0.049 | 0.195 | Sodium channel (voltage-gated) blocker | 0.195 0.031 DBMET00245 | DBMET00245 | |
| 0.14 | 0.031 | 0.14 | Alpha 1 adrenoreceptor antagonist | 0.132 0.033 DBMET00245 | ||
| 0.163 | 0.055 | 0.171 | Toll-Like receptor 9 antagonist | 0.171 0.05 DBMET00245 | DBMET00245 | |
| 0.118 | 0.011 | 0.118 | Estrogen-related receptor beta agonist | 0.094 0.034 DBMET00245 | ||
| 0.223 | 0.115 | 0.258 | Gastrin inhibitor | 0.258 0.07 DBMET00245 | DBMET00245 | |
| 0.17 | 0.065 | 0.17 | Arachidonic acid antagonist | |||
| 0.108 | 0.005 | 0.108 | Bcl-xL inhibitor | |||
| 0.121 | 0.02 | 0.121 | Dopamine D3 antagonist | 0.095 0.026 DBMET00245 | ||
| 0.137 | 0.036 | 0.137 | Carbonic anhydrase XV inhibitor | 0.115 0.05 DBMET00245 | ||
| 0.119 | 0.018 | 0.132 | Glycine receptor antagonist | 0.132 0.013 DBMET02774 0.096 0.036 DBMET00245 | DBMET02774 | |
| 0.134 | 0.034 | 0.134 | Ca(v)2.2 blocker | 0.092 0.055 DBMET00245 | ||
| 0.155 | 0.055 | 0.181 | Sodium channel blocker | 0.181 0.04 DBMET00245 | DBMET00245 | |
| 0.247 | 0.15 | 0.351 | Calcium channel activator | 0.351 0.049 DBMET00245 | DBMET00245 | |
| 0.198 | 0.102 | 0.198 | RNA-directed DNA polymerase inhibitor | |||
| 0.138 | 0.043 | 0.138 | DNA repair enzyme inhibitor | 0.12 0.071 DBMET00245 | ||
| 0.123 | 0.029 | 0.123 | Alpha 1a adrenoreceptor antagonist | 0.123 0.029 DBMET00245 | ||
| 0.172 | 0.078 | 0.177 | Succinate dehydrogenase inhibitor | 0.177 0.071 DBMET00245 | DBMET00245 | |
| 0.101 | 0.007 | 0.101 | Potassium channel (Inward rectifier) blocker | 0.085 0.01 DBMET00245 | ||
| 0.122 | 0.032 | 0.122 | Dopamine antagonist | 0.093 0.041 DBMET00245 | ||
| 0.145 | 0.056 | 0.145 | Ca2+-transporting ATPase inhibitor | 0.134 0.1 DBMET02774 0.136 0.089 DBMET00245 | ||
| 0.188 | 0.1 | 0.188 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.104 | 0.016 | 0.104 | 5 Hydroxytryptamine 3 antagonist | 0.063 0.033 DBMET00245 | ||
| 0.094 | 0.008 | 0.094 | 5 Hydroxytryptamine 4 antagonist | 0.089 0.01 DBMET00245 | ||
| 0.201 | 0.116 | 0.234 | Superoxide dismutase inhibitor | 0.234 0.086 DBMET00245 | DBMET00245 | |
| 0.091 | 0.007 | 0.091 | Squalene epoxidase inhibitor | 0.073 0.012 DBMET00245 | ||
| 0.127 | 0.044 | 0.127 | Nav1.1 sodium channel blocker | 0.105 0.06 DBMET00245 | ||
| 0.087 | 0.005 | 0.087 | Adenylate cyclase 1 inhibitor | 0.07 0.012 DBMET00245 | ||
| 0.153 | 0.071 | 0.153 | CF transmembrane conductance regulator agonist | |||
| 0.119 | 0.038 | 0.174 | Nitric-oxide synthase inhibitor | 0.174 0.015 DBMET00245 | DBMET00245 | |
| 0.093 | 0.013 | 0.121 | Dopamine transporter inhibitor | 0.121 0.008 DBMET00245 | DBMET00245 | |
| 0.19 | 0.112 | 0.323 | Peptidyltransferase inhibitor | 0.323 0.018 DBMET02774 0.313 0.02 DBMET00245 | DBMET02774 | |
| 0.095 | 0.017 | 0.095 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.09 0.022 DBMET00245 | ||
| 0.124 | 0.048 | 0.124 | Estrogen antagonist | 0.103 0.091 DBMET00245 | ||
| 0.118 | 0.042 | 0.179 | GABA C receptor rho-1 antagonist | 0.179 0.012 DBMET00245 | DBMET00245 | |
| 0.129 | 0.053 | 0.129 | Calcium channel N-type blocker | 0.117 0.067 DBMET00245 | ||
| 0.14 | 0.065 | 0.14 | Interleukin 1 antagonist | |||
| 0.099 | 0.026 | 0.099 | Dopamine D4 antagonist | 0.053 0.047 DBMET00245 | ||
| 0.083 | 0.011 | 0.097 | 5 Hydroxytryptamine 1B agonist | 0.097 0.008 DBMET00245 | DBMET00245 | |
| 0.118 | 0.048 | 0.118 | Butyrylcholinesterase inhibitor | |||
| 0.085 | 0.015 | 0.11 | Beta 1 adrenoreceptor antagonist | 0.11 0.008 DBMET00245 | DBMET00245 | |
| 0.136 | 0.066 | 0.136 | MAO inhibitor | 0.102 0.089 DBMET00245 | ||
| 0.111 | 0.041 | 0.111 | Lanosterol 14 alpha demethylase inhibitor | 0.09 0.071 DBMET02774 0.099 0.058 DBMET00245 | ||
| 0.111 | 0.043 | 0.111 | Protein kinase C delta inhibitor | 0.094 0.058 DBMET00245 | ||
| 0.089 | 0.021 | 0.115 | Beta adrenoreceptor antagonist | 0.115 0.011 DBMET00245 | DBMET00245 | |
| 0.071 | 0.005 | 0.071 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.098 | 0.033 | 0.098 | Dopamine D2 antagonist | 0.064 0.047 DBMET00245 | ||
| 0.132 | 0.067 | 0.18 | Alpha-N-acetylglucosaminidase inhibitor | 0.18 0.041 DBMET02774 0.147 0.057 DBMET00245 | DBMET02774 | |
| 0.094 | 0.03 | 0.094 | CC chemokine 5 receptor agonist | 0.08 0.065 DBMET00245 | ||
| 0.067 | 0.004 | 0.067 | Urotensin II agonist | |||
| 0.102 | 0.04 | 0.114 | Glutamate release inhibitor | 0.114 0.026 DBMET00245 | DBMET00245 | |
| 0.083 | 0.022 | 0.083 | Androgen agonist | 0.063 0.037 DBMET00245 | ||
| 0.085 | 0.027 | 0.102 | Phospholipase D inhibitor | 0.102 0.014 DBMET00245 | DBMET00245 | |
| 0.122 | 0.064 | 0.122 | Cholesterol synthesis inhibitor | |||
| 0.073 | 0.015 | 0.096 | Beta 2 adrenoreceptor antagonist | 0.096 0.008 DBMET00245 | DBMET00245 | |
| 0.071 | 0.014 | 0.071 | Opioid kappa receptor agonist | 0.052 0.023 DBMET00245 | ||
| 0.152 | 0.096 | 0.179 | Neurotensin receptor agonist | 0.179 0.05 DBMET00245 | DBMET00245 | |
| 0.16 | 0.104 | 0.16 | Non-steroidal antiinflammatory agent | 0.158 0.106 DBMET00245 | ||
| 0.129 | 0.073 | 0.129 | Toll-Like receptor antagonist | 0.121 0.083 DBMET00245 | ||
| 0.092 | 0.036 | 0.092 | Interferon agonist | |||
| 0.093 | 0.038 | 0.093 | Na+ K+ transporting ATPase inhibitor | |||
| 0.128 | 0.073 | 0.128 | Tubulin antagonist | 0.114 0.086 DBMET00245 | ||
| 0.094 | 0.041 | 0.094 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.079 | 0.026 | 0.079 | Exportin-1 inhibitor | |||
| 0.108 | 0.055 | 0.123 | Adenylate kinase inhibitor | 0.123 0.041 DBMET02774 0.104 0.061 DBMET00245 | DBMET02774 | |
| 0.113 | 0.062 | 0.142 | 5 Hydroxytryptamine 3A agonist | 0.142 0.04 DBMET00245 | DBMET00245 | |
| 0.141 | 0.089 | 0.141 | Cyclin-dependent kinase 8 inhibitor | 0.139 0.091 DBMET00245 | ||
| 0.055 | 0.005 | 0.055 | Estrogen-related receptor beta antagonist | 0.035 0.017 DBMET00245 | ||
| 0.112 | 0.062 | 0.118 | Acetylcholine release stimulant | 0.118 0.051 DBMET00245 | DBMET00245 | |
| 0.069 | 0.018 | 0.072 | Nicotinic alpha3beta2 receptor antagonist | 0.072 0.017 DBMET00245 | DBMET00245 | |
| 0.07 | 0.02 | 0.07 | 5 Hydroxytryptamine 7 agonist | 0.06 0.031 DBMET00245 | ||
| 0.067 | 0.018 | 0.067 | Topoisomerase II beta inhibitor | |||
| 0.118 | 0.07 | 0.21 | Alkylator | 0.21 0.024 DBMET02774 0.117 0.071 DBMET00245 | DBMET02774 | |
| 0.092 | 0.045 | 0.099 | Myeloperoxidase inhibitor | 0.099 0.036 DBMET00245 | DBMET00245 | |
| 0.057 | 0.01 | 0.074 | Histamine H1 receptor agonist | 0.074 0.004 DBMET00245 | DBMET00245 | |
| 0.06 | 0.013 | 0.06 | Geranyltranstransferase inhibitor | 0.047 0.026 DBMET00245 | ||
| 0.079 | 0.032 | 0.079 | Protein kinase C beta inhibitor | 0.063 0.062 DBMET00245 | ||
| 0.103 | 0.058 | 0.103 | Estrogen receptor beta antagonist | |||
| 0.152 | 0.107 | 0.152 | Amyloid beta aggregation inhibitor | |||
| 0.058 | 0.015 | 0.058 | Benzodiazepine antagonist | |||
| 0.103 | 0.059 | 0.103 | Carbonic anhydrase III inhibitor | |||
| 0.163 | 0.12 | 0.184 | Neurotrophic factor enhancer | 0.184 0.093 DBMET00245 | DBMET00245 | |
| 0.094 | 0.051 | 0.115 | NADH dehydrogenase inhibitor | 0.115 0.031 DBMET02774 | DBMET02774 | |
| 0.055 | 0.012 | 0.06 | Diamine oxidase inhibitor | 0.06 0.009 DBMET00245 | DBMET00245 | |
| 0.079 | 0.037 | 0.079 | Potassium channel (Tandem pore domain) blocker | 0.076 0.045 DBMET00245 | ||
| 0.054 | 0.013 | 0.054 | GABA uptake inhibitor | |||
| 0.06 | 0.019 | 0.06 | Dopamine D5 antagonist | |||
| 0.099 | 0.06 | 0.099 | Creatine kinase inhibitor | 0.084 0.081 DBMET00245 | ||
| 0.043 | 0.004 | 0.043 | Estrogen-related receptor gamma antagonist | 0.031 0.014 DBMET00245 | ||
| 0.122 | 0.084 | 0.14 | Vanilloid 1 agonist | 0.14 0.05 DBMET00245 | DBMET00245 | |
| 0.089 | 0.053 | 0.089 | Granulocyte macrophage colony stimulating factor agonist | 0.084 0.065 DBMET00245 | ||
| 0.054 | 0.019 | 0.079 | Histamine H2 receptor agonist | 0.079 0.007 DBMET00245 | DBMET00245 | |
| 0.076 | 0.041 | 0.125 | Phenylalanine 4-hydroxylase inhibitor | 0.125 0.017 DBMET00245 | DBMET00245 | |
| 0.094 | 0.059 | 0.094 | Protein kinase C zeta inhibitor | |||
| 0.06 | 0.025 | 0.072 | Immunoglobulin Fc receptor antagonist | 0.072 0.01 DBMET00245 | DBMET00245 | |
| 0.115 | 0.083 | 0.142 | Toll-Like receptor 2 antagonist | 0.142 0.058 DBMET00245 | DBMET00245 | |
| 0.06 | 0.028 | 0.061 | Epithelial sodium channel blocker | 0.061 0.027 DBMET00245 | DBMET00245 | |
| 0.112 | 0.08 | 0.124 | Aldehyde dehydrogenase inhibitor | 0.124 0.067 DBMET00245 | DBMET00245 | |
| 0.095 | 0.064 | 0.095 | Phosphodiesterase 6D inhibitor | |||
| 0.079 | 0.048 | 0.079 | Porphobilinogen synthase inhibitor | |||
| 0.135 | 0.105 | 0.137 | Melanin inhibitor | 0.132 0.11 DBMET02774 0.137 0.102 DBMET00245 | DBMET00245 | |
| 0.062 | 0.032 | 0.062 | Acetylcholine muscarinic agonist | |||
| 0.103 | 0.073 | 0.103 | GABA receptor agonist | 0.096 0.081 DBMET00245 | ||
| 0.072 | 0.043 | 0.077 | Dopamine agonist | 0.077 0.039 DBMET00245 | DBMET00245 | |
| 0.096 | 0.069 | 0.096 | Anabolic | 0.087 0.084 DBMET00245 | ||
| 0.081 | 0.054 | 0.082 | Acetylcholine nicotinic antagonist | 0.082 0.052 DBMET00245 | DBMET00245 | |
| 0.033 | 0.006 | 0.033 | Protease (Human cytomegalovirus) inhibitor | 0.026 0.011 DBMET00245 | ||
| 0.04 | 0.014 | 0.04 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.129 | 0.103 | 0.129 | Pregnane X receptor agonist | |||
| 0.045 | 0.02 | 0.065 | Histone deacetylase 9 inhibitor | 0.065 0.01 DBMET00245 | DBMET00245 | |
| 0.078 | 0.053 | 0.078 | Estrogen receptor alpha antagonist | |||
| 0.111 | 0.087 | 0.138 | Cathepsin H inhibitor | 0.138 0.056 DBMET00245 | DBMET00245 | |
| 0.069 | 0.045 | 0.089 | Sphingosine 1-phosphate receptor 4 agonist | 0.089 0.031 DBMET00245 | DBMET00245 | |
| 0.122 | 0.098 | 0.122 | Peroxidase inhibitor | 0.121 0.099 DBMET00245 | ||
| 0.065 | 0.042 | 0.065 | Interferon inducer | |||
| 0.038 | 0.015 | 0.038 | 5 Hydroxytryptamine 1D agonist | 0.028 0.02 DBMET00245 | ||
| 0.076 | 0.053 | 0.076 | Analgesic, opioid | |||
| 0.038 | 0.015 | 0.059 | Melatonin receptor 1A agonist | 0.059 0.005 DBMET00245 | DBMET00245 | |
| 0.054 | 0.031 | 0.054 | Prolyl endopeptidase inhibitor | |||
| 0.067 | 0.045 | 0.067 | Bcl2 antagonist | |||
| 0.063 | 0.041 | 0.063 | Prolactin release inhibitor | |||
| 0.083 | 0.062 | 0.083 | Acetylcholine agonist | |||
| 0.047 | 0.027 | 0.047 | Acetylcholine M1 receptor agonist | |||
| 0.132 | 0.112 | 0.132 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.045 | 0.025 | 0.045 | Nerve growth factor antagonist | 0.041 0.033 DBMET00245 | ||
| 0.074 | 0.054 | 0.09 | Vanilloid 4 agonist | 0.09 0.026 DBMET00245 | DBMET00245 | |
| 0.033 | 0.014 | 0.033 | 5 Hydroxytryptamine 6 agonist | |||
| 0.074 | 0.055 | 0.074 | GABA aminotransferase inhibitor | |||
| 0.038 | 0.022 | 0.038 | Retinoid X alpha receptor agonist | |||
| 0.045 | 0.029 | 0.045 | Histamine H3 receptor antagonist | |||
| 0.247 | 0.232 | 0.252 | 5 Hydroxytryptamine release inhibitor | 0.252 0.225 DBMET00245 | DBMET00245 | |
| 0.028 | 0.013 | 0.03 | Acid ceramidase inhibitor | 0.03 0.009 DBMET00245 | DBMET00245 | |
| 0.085 | 0.07 | 0.085 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.096 | 0.082 | 0.096 | Cystathionine beta-synthase inhibitor | |||
| 0.059 | 0.044 | 0.059 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.089 | 0.076 | 0.089 | Chemokine receptor antagonist | |||
| 0.067 | 0.055 | 0.067 | Benzodiazepine agonist | |||
| 0.059 | 0.048 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.068 | 0.056 | 0.084 | Aminopeptidase I inhibitor | 0.084 0.039 DBMET00245 | DBMET00245 | |
| 0.02 | 0.01 | 0.02 | Estrogen-related receptor gamma agonist | 0.019 0.013 DBMET00245 | ||
| 0.112 | 0.101 | 0.158 | Protein kinase stimulant | 0.116 0.097 DBMET02774 0.158 0.063 DBMET00245 | DBMET00245 | |
| 0.028 | 0.017 | 0.028 | Myristoyl transferase inhibitor | 0.028 0.018 DBMET00245 | ||
| 0.052 | 0.042 | 0.062 | Thromboxane synthase inhibitor | 0.062 0.024 DBMET00245 | DBMET00245 | |
| 0.049 | 0.04 | 0.049 | Aconitate hydratase inhibitor | |||
| 0.039 | 0.029 | 0.04 | Dopamine D5 agonist | 0.04 0.028 DBMET00245 | DBMET00245 | |
| 0.041 | 0.032 | 0.041 | Guanylate cyclase inhibitor | |||
| 0.035 | 0.025 | 0.035 | Opioid delta receptor agonist | 0.032 0.03 DBMET00245 | ||
| 0.027 | 0.019 | 0.027 | Hedgehog signaling activator | |||
| 0.061 | 0.053 | 0.07 | Neuronal nicotinic receptor antagonist | 0.07 0.045 DBMET00245 | DBMET00245 | |
| 0.045 | 0.037 | 0.045 | Sigma receptor antagonist | |||
| 0.063 | 0.056 | 0.063 | Glutamate (mGluR7) antagonist | |||
| 0.067 | 0.06 | 0.086 | Glutamate dehydrogenase inhibitor | 0.086 0.039 DBMET02774 0.078 0.047 DBMET00245 | DBMET02774 | |
| 0.025 | 0.018 | 0.027 | Vanilloid 2 agonist | 0.024 0.02 DBMET02774 0.027 0.014 DBMET00245 | DBMET00245 | |
| 0.084 | 0.078 | 0.108 | Aminopeptidase B inhibitor | 0.108 0.06 DBMET00245 | DBMET00245 | |
| 0.016 | 0.011 | 0.016 | Prostacyclin agonist | |||
| 0.015 | 0.01 | 0.015 | NMDA receptor phencyclidine site antagonist | |||
| 0.014 | 0.009 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.049 | 0.046 | 0.049 | Leukotriene B4 antagonist | 0.049 0.047 DBMET02774 | ||
| 0.06 | 0.058 | 0.06 | Calcium channel P-type blocker | |||
| 0.043 | 0.041 | 0.043 | CC chemokine 4 receptor antagonist | |||
| 0.025 | 0.024 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.033 | 0.032 | 0.033 | Factor XIIIa inhibitor | |||
| 0.067 | 0.066 | 0.097 | Nicotinic alpha4beta2 receptor antagonist | 0.097 0.034 DBMET00245 | DBMET00245 | |
| 0.045 | 0.044 | 0.048 | Dopamine beta hydroxylase inhibitor | 0.048 0.036 DBMET00245 | DBMET00245 | |
| 0.079 | 0.079 | 0.097 | Triose-phosphate isomerase inhibitor | 0.097 0.051 DBMET02774 0.079 0.078 DBMET00245 | DBMET02774 | |
| 0.032 | 0.032 | 0.035 | Ceramide glucosyltransferase inhibitor | 0.035 0.025 DBMET00245 | DBMET00245 | |
| 0.044 | 0.045 | 0.051 | 5 Hydroxytryptamine 2 agonist | 0.051 0.037 DBMET00245 | DBMET00245 | |
| 0.03 | 0.034 | 0.048 | Histone deacetylase 7 inhibitor | 0.048 0.019 DBMET00245 | DBMET00245 | |
| 0.032 | 0.037 | 0.059 | Alpha 1d adrenoreceptor agonist | 0.059 0.011 DBMET00245 | DBMET00245 | |
| 0.032 | 0.038 | 0.04 | Delayed rectifier potassium channel blocker | 0.04 0.022 DBMET00245 | DBMET00245 | |
| 0.048 | 0.056 | 0.061 | Biliverdin reductase inhibitor | 0.061 0.04 DBMET02774 | DBMET02774 | |
| 0.025 | 0.033 | 0.04 | Sirtuin 2 inhibitor | 0.04 0.017 DBMET00245 | DBMET00245 | |
| 0.155 | 0.163 | 0.223 | Interleukin agonist | 0.223 0.1 DBMET00245 | DBMET00245 | |
| 0.016 | 0.025 | 0.024 | Dopamine autoreceptor agonist | 0.024 0.017 DBMET00245 | DBMET00245 | |
| 0.097 | 0.105 | 0.119 | Interleukin 8 antagonist | 0.119 0.063 DBMET00245 | DBMET00245 | |
| 0.094 | 0.103 | 0.1 | Microtubule formation inhibitor | 0.1 0.091 DBMET00245 | DBMET00245 | |
| 0.044 | 0.052 | 0.06 | Histamine agonist | 0.06 0.027 DBMET00245 | DBMET00245 | |
| 0.041 | 0.05 | 0.046 | Glucose-6-phosphate isomerase inhibitor | 0.046 0.036 DBMET02774 | DBMET02774 | |
| 0.032 | 0.042 | 0.036 | Membrane dipeptidase inhibitor | 0.036 0.034 DBMET00245 | DBMET00245 | |
| 0.035 | 0.046 | 0.039 | Angiotensin AT1 receptor antagonist | 0.039 0.035 DBMET00245 | DBMET00245 | |
| 0.038 | 0.048 | 0.046 | Thromboxane A2 antagonist | 0.046 0.039 DBMET00245 | DBMET00245 | |
| 0.055 | 0.067 | 0.074 | Histone deacetylase SIRT3 inhibitor | 0.074 0.023 DBMET00245 | DBMET00245 | |
| 0.012 | 0.027 | 0.016 | Histamine H4 receptor agonist | 0.016 0.015 DBMET00245 | DBMET00245 | |
| 0.051 | 0.066 | 0.084 | NMDA receptor agonist | 0.084 0.027 DBMET00245 | DBMET00245 | |
| 0.023 | 0.038 | 0.031 | Purinergic P2Y15 antagonist | 0.031 0.015 DBMET00245 | DBMET00245 | |
| 0.064 | 0.08 | 0.077 | Acetylcholine nicotinic agonist | 0.077 0.062 DBMET00245 | DBMET00245 | |
| 0.019 | 0.034 | 0.024 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.019 DBMET00245 | DBMET00245 | |
| 0.053 | 0.069 | 0.067 | Histone deacetylase inhibitor | 0.067 0.043 DBMET00245 | DBMET00245 | |
| 0.075 | 0.092 | 0.089 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.089 0.066 DBMET02774 | DBMET02774 | |
| 0.027 | 0.044 | 0.031 | Angiotensin II receptor antagonist | 0.031 0.03 DBMET00245 | DBMET00245 | |
| 0.053 | 0.07 | 0.059 | Protease 3C (Human rhinovirus) inhibitor | 0.059 0.055 DBMET00245 | DBMET00245 | |
| 0.015 | 0.033 | 0.021 | Leukotriene B4 receptor 2 antagonist | 0.021 0.017 DBMET02774 | DBMET02774 | |
| 0.019 | 0.039 | 0.032 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.014 DBMET00245 | DBMET00245 | |
| 0.049 | 0.07 | 0.111 | Phosphofructokinase-1 inhibitor | 0.111 0.028 DBMET02774 | DBMET02774 | |
| 0.082 | 0.107 | 0.13 | Glutamate (mGluR7) agonist | 0.13 0.022 DBMET00245 | DBMET00245 | |
| 0.026 | 0.052 | 0.035 | Histone deacetylase 8 inhibitor | 0.035 0.034 DBMET00245 | DBMET00245 | |
| 0.074 | 0.102 | 0.127 | UDP-glucose 4-epimerase inhibitor | 0.127 0.039 DBMET02774 | DBMET02774 | |
| 0.008 | 0.039 | 0.025 | KiSS-1 receptor antagonist | 0.025 0.006 DBMET00245 | DBMET00245 | |
| 0.008 | 0.04 | 0.014 | Melatonin receptor 1A antagonist | 0.014 0.009 DBMET00245 | DBMET00245 | |
| 0.059 | 0.092 | 0.109 | Ornithine decarboxylase inhibitor | 0.109 0.035 DBMET00245 | DBMET00245 | |
| 0.07 | 0.106 | 0.077 | D-Ala-D-Ala ligase inhibitor | 0.077 0.076 DBMET00245 | DBMET00245 | |
| 0.134 | 0.17 | 0.439 | Immunostimulant | 0.439 0.039 DBMET02774 | DBMET02774 | |
| 0.038 | 0.075 | 0.08 | Alpha-mannosidase inhibitor | 0.08 0.011 DBMET02774 | DBMET02774 | |
| 0.084 | 0.123 | 0.107 | Factor V inhibitor | 0.107 0.055 DBMET00245 | DBMET00245 | |
| 0.041 | 0.081 | 0.063 | Alpha 2 adrenoreceptor agonist | 0.063 0.038 DBMET00245 | DBMET00245 | |
| 0.015 | 0.058 | 0.029 | Endothelial nitric-oxide synthase inhibitor | 0.029 0.025 DBMET00245 | DBMET00245 | |
| 0.05 | 0.094 | 0.059 | Heme oxygenase stimulant | 0.059 0.05 DBMET00245 | DBMET00245 | |
| 0.018 | 0.063 | 0.029 | Thrombin receptor antagonist | 0.029 0.019 DBMET00245 | DBMET00245 | |
| 0.061 | 0.106 | 0.105 | Inducible nitric-oxide synthase inhibitor | 0.105 0.033 DBMET00245 | DBMET00245 | |
| 0.039 | 0.086 | 0.09 | Carbonic anhydrase stimulant | 0.09 0.022 DBMET00245 | DBMET00245 | |
| 0.009 | 0.058 | 0.018 | Alpha 2c adrenoreceptor agonist | 0.018 0.013 DBMET00245 | DBMET00245 | |
| 0.008 | 0.061 | 0.017 | Alpha 2a adrenoreceptor agonist | 0.017 0.012 DBMET00245 | DBMET00245 | |
| 0.006 | 0.059 | 0.031 | Ileal bile acid transport inhibitor | 0.031 0.005 DBMET02774 | DBMET02774 | |
| 0.152 | 0.205 | 0.173 | Nitric-oxide synthase stimulant | 0.173 0.144 DBMET00245 | DBMET00245 | |
| 0.115 | 0.17 | 0.168 | I kappa B kinase epsilon inhibitor | 0.168 0.101 DBMET00245 | DBMET00245 | |
| 0.022 | 0.08 | 0.058 | NMDA 2A receptor antagonist | 0.058 0.031 DBMET00245 | DBMET00245 | |
| 0.038 | 0.096 | 0.056 | Glucosylceramidase inhibitor | 0.056 0.036 DBMET02774 | DBMET02774 | |
| 0.025 | 0.086 | 0.073 | Mannosidase inhibitor | 0.073 0.01 DBMET02774 | DBMET02774 | |
| 0.129 | 0.192 | 0.152 | Histone acetyltransferase inhibitor | 0.152 0.136 DBMET00245 | DBMET00245 | |
| 0.016 | 0.086 | 0.039 | Melatonin 2 agonist | 0.039 0.016 DBMET00245 | DBMET00245 | |
| 0.194 | 0.284 | 0.583 | Calcium channel L-type activator | 0.583 0.008 DBMET00245 | DBMET00245 | |
| 0.021 | 0.115 | 0.081 | Carbonic anhydrase XIV inhibitor | 0.081 0.016 DBMET02774 | DBMET02774 | |
| 0.161 | 0.258 | 0.589 | Toll-Like receptor 7 agonist | 0.589 0.019 DBMET02774 | DBMET02774 | |
| 0.161 | 0.258 | 0.591 | Toll-Like receptor agonist | 0.591 0.018 DBMET02774 | DBMET02774 | |
| 0.015 | 0.114 | 0.033 | Melatonin 1 agonist | 0.033 0.023 DBMET00245 | DBMET00245 | |
| 0.014 | 0.117 | 0.032 | Melatonin agonist | 0.032 0.023 DBMET00245 | DBMET00245 | |
| 0.03 | 0.137 | 0.073 | Heparanase inhibitor | 0.073 0.01 DBMET02774 | DBMET02774 | |
| 0.051 | 0.163 | 0.115 | Expectorant | 0.115 0.054 DBMET02774 | DBMET02774 | |
| 0.008 | 0.122 | 0.027 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.017 DBMET02774 | DBMET02774 | |
| 0.014 | 0.14 | 0.066 | Phosphorylase inhibitor | 0.066 0.022 DBMET02774 | DBMET02774 | |
| 0.04 | 0.17 | 0.071 | Adrenaline agonist | 0.071 0.07 DBMET00245 | DBMET00245 | |
| 0.006 | 0.142 | 0.029 | Squalene synthetase inhibitor | 0.029 0.024 DBMET02774 | DBMET02774 | |
| 0.01 | 0.154 | 0.028 | Sodium/glucose cotransporter inhibitor | 0.028 0.013 DBMET02774 | DBMET02774 | |
| 0.054 | 0.213 | 0.259 | Lipid peroxidase inhibitor | 0.259 0.025 DBMET02774 | DBMET02774 | |
| 0.018 | 0.178 | 0.047 | Antibiotic Aminoglycoside-like | 0.047 0.015 DBMET02774 | DBMET02774 | |
| 0.049 | 0.22 | 0.141 | Beta glucuronidase inhibitor | 0.141 0.029 DBMET02774 | DBMET02774 | |
| 0.09 | 0.278 | 0.14 | Lipocortins synthesis antagonist | 0.14 0.121 DBMET02774 | DBMET02774 | |
| 0.13 | 0.334 | 0.553 | Antibacterial | 0.553 0.028 DBMET02774 | DBMET02774 | |
| 0.071 | 0.279 | 0.262 | Hepatoprotectant | 0.262 0.04 DBMET02774 | DBMET02774 | |
| 0.083 | 0.294 | 0.341 | Antioxidant | 0.341 0.049 DBMET02774 | DBMET02774 | |
| 0.109 | 0.321 | 0.333 | Immunosuppressant | 0.333 0.096 DBMET02774 | DBMET02774 | |
| 0.042 | 0.259 | 0.103 | Histone deacetylase class III inhibitor | 0.103 0.086 DBMET00245 | DBMET00245 | |
| 0.056 | 0.281 | 0.163 | Histone deacetylase SIRT1 inhibitor | 0.163 0.051 DBMET00245 | DBMET00245 | |
| 0.05 | 0.281 | 0.221 | Toll-Like receptor 3 antagonist | 0.221 0.005 DBMET00245 | DBMET00245 | |
| 0.065 | 0.3 | 0.167 | Nitric oxide antagonist | 0.167 0.083 DBMET02774 | DBMET02774 | |
| 0.015 | 0.257 | 0.047 | Baculoviral IAP repeat-containing protein inhibitor | 0.047 0.031 DBMET00245 | DBMET00245 | |
| 0.138 | 0.383 | 0.566 | Cyclophilin D inhibitor | 0.566 0.034 DBMET02774 | DBMET02774 | |
| 0.06 | 0.311 | 0.259 | Hypolipemic | 0.259 0.063 DBMET02774 | DBMET02774 | |
| 0.04 | 0.301 | 0.128 | DNA polymerase I inhibitor | 0.128 0.063 DBMET02774 | DBMET02774 | |
| 0.003 | 0.271 | 0.011 | Retinoic acid receptor gamma antagonist | 0.011 0.01 DBMET02774 | DBMET02774 | |
| 0.093 | 0.365 | 0.13 | CC chemokine 6 receptor antagonist | 0.13 0.072 DBMET02774 | DBMET02774 | |
| 0.019 | 0.314 | 0.052 | Glucose-6-phosphate translocase inhibitor | 0.052 0.034 DBMET02774 | DBMET02774 | |
| 0.032 | 0.338 | 0.146 | Thrombolytic | 0.146 0.085 DBMET02774 | DBMET02774 | |
| 0.036 | 0.382 | 0.105 | Toll-Like receptor 4 antagonist | 0.105 0.061 DBMET02774 | DBMET02774 | |
| 0.006 | 0.361 | 0.098 | Antineoplastic antibiotic | 0.098 0.047 DBMET02774 | DBMET02774 | |
| 0.033 | 0.47 | 0.25 | Free radical scavenger | 0.25 0.068 DBMET02774 | DBMET02774 | |
| 0.006 | 0.512 | 0.215 | Selectin antagonist | 0.215 0.01 DBMET02774 | DBMET02774 | |
| 0.015 | 0.524 | 0.055 | Bombesin 1 receptor agonist | 0.055 0.048 DBMET00245 | DBMET00245 | |
| 0.026 | 0.537 | 0.055 | Lipocortins synthesis agonist | 0.055 0.049 DBMET02774 | DBMET02774 | |
| 0.022 | 0.538 | 0.373 | Angiogenesis stimulant | 0.373 0.027 DBMET02774 | DBMET02774 | |
| 0.077 | 0.613 | 0.277 | Interleukin 2 agonist | 0.277 0.092 DBMET02774 | DBMET02774 | |
| 0.015 | 0.575 | 0.072 | Factor IXa inhibitor | 0.072 0.019 DBMET02774 | DBMET02774 | |
| 0.01 | 0.88 | 0.156 | Platelet adhesion inhibitor | 0.156 0.1 DBMET02774 | DBMET02774 | |
| 0.009 | 0.9 | 0.193 | Hypoglycemic | 0.193 0.12 DBMET02774 | DBMET02774 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |